+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Gene expression profiling: canonical molecular changes and clinicopathological features in sporadic colorectal cancers

Gene expression profiling: canonical molecular changes and clinicopathological features in sporadic colorectal cancers

World Journal of Gastroenterology 14(43): 6662-6672

To investigate alternative or subordinate pathways involved in colorectal tumorigenesis and tumor growth, possibly determining at-risk populations and predicting responses to treatment. Using microarray gene-expression analysis, we analyzed patterns of gene expression relative to canonical molecular changes and clinicopathological features in 84 sporadic colorectal cancer patients, standardized by tumor location. Subsets of differentially expressed genes were confirmed by real-time reverse-transcript polymerase chain reaction (RT-PCR). The largest number of genes identified as being differentially expressed was by tumor location, and the next largest number by lymphovascular or neural invasion of tumor cells and by mismatch repair (MMR) defects. Amongst biological processes, the immune response was significantly implicated in entire molecular changes observed during colorectal tumorigenesis (P < 0.001). Amongst 47 differentially expressed genes, seven (PISD, NIBP, BAI2, STOML1, MRPL21, MRPL16, and MKKS) were newly found to correlate with tumorigenesis and tumor growth. Most location-associated molecular changes had distinct effects on gene expression, but the effects of the latter were sometimes contradictory. We show that several differentially expressed genes were associated with canonical molecular changes in sporadic colorectal cancers, possibly constituting alternative or subordinate pathways of tumorigenesis. As tumor location was the dominant factor influencing differential gene expression, location-specific analysis may identify location-associated pathways and enhance the accuracy of class prediction.

(PDF emailed within 1 workday: $29.90)

Accession: 053365358

Download citation: RISBibTeXText

PMID: 19034969

Related references

Difference between proximal and distal microsatellite-unstable sporadic colorectal cancers: analysis of clinicopathological and molecular features and prognoses. Annals of Surgical Oncology 17(5): 1435-1441, 2010

Role of topoisomerase I and thymidylate synthase expression in sporadic colorectal cancer: associations with clinicopathological and molecular features. Pathology, Research and Practice 210(2): 111-117, 2015

Sporadic colorectal cancers with defective mismatch repair display a number of specific morphological characteristics: Relationship between the expression of hMLH1 and hMSH2 proteins and clinicopathological features of 273 adenocarcinomas. Histopathology 43(1): 40-47, 2003

HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers. International Journal of Cancer 125(5): 1231-1237, 2009

Relationship between COX-2 expression and clinicopathological features of colorectal cancers. Chinese Medical Journal 117(8): 1151-1154, 2004

Clinicopathologic and molecular features of sporadic microsatellite- and chromosomal-stable colorectal cancers. International Journal of Colorectal Disease 23(4): 365-373, 2008

Sporadic colorectal carcinomas with low-level microsatellite instability: a distinct subgroup with specific clinicopathological and molecular features. International Journal of Colorectal Disease 26(4): 445-453, 2011

The differences between three distinct locations of colorectal cancers based on clinicopathological characteristics and molecular features. Zhonghua Yu Fang Yi Xue Za Zhi 48(12): 1078-1082, 2015

Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. Bmc Cancer 10: 227, 2010

Subcellular expression of c-IAP1 and c-IAP2 in colorectal cancers: relationships with clinicopathological features and prognosis. Pathology, Research and Practice 199(11): 723-731, 2004

Clinico-pathological features and p53 expression in left-sided sporadic colorectal cancers with and without microsatellite instability. Journal of Pathology 179(4): 370-375, 1996

May the APC gene somatic mutations in tumor tissues influence the clinical features of Chinese sporadic colorectal cancers?. Acta Oncologica 46(6): 757-762, 2007

Gene expression profiling of hereditary and sporadic ovarian cancers reveals unique BRCA1 and BRCA2 signatures. Journal of the National Cancer Institute 94(13): 960-961, 2002

Gene Expression Profiling of Colorectal Cancer and Metastases Divides Tumours According to Their Clinicopathological Stage. Yearbook of Pathology and Laboratory Medicine 2006: 26-27, 2006

Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage. Journal of Pathology 204(1): 65-74, 2004